Heterotrimeric G-Protein, G(alpha 16), Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Canceropen access
- Authors
- Avasarala, Sreedevi; Bikkavilli, Rama Kamesh; Van Scoyk, Michelle; Zhang, Wei; Lapite, Ajibike; Hostetter, Logan; Byers, Joshua T.; Heasley, Lynn E.; Sohn, Jang Won; Winn, Robert A.
- Issue Date
- Oct-2013
- Publisher
- PUBLIC LIBRARY SCIENCE
- Citation
- PLOS ONE, v.8, no.10, pp.1 - 11
- Indexed
- SCIE
SCOPUS
- Journal Title
- PLOS ONE
- Volume
- 8
- Number
- 10
- Start Page
- 1
- End Page
- 11
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161869
- DOI
- 10.1371/journal.pone.0076895
- ISSN
- 1932-6203
- Abstract
- G-protein-coupled receptors (GPCR) are the largest family of cell surface molecules that play important role/s in a number of biological and pathological processes including cancers. Earlier studies have highlighted the importance of Wnt7a signaling via its cognate receptor Frizzled9, a GPCR, in inhibition of cell proliferation, anchorage-independent growth, and reversal of transformed phenotype in non small cell lung cancer primarily through activation of the tumor suppressor, PPAR gamma. However, the G-protein effectors that couple to this important tumor suppressor pathway have not been identified, and are of potential therapeutic interest. In this study, by using two independent Wnt7a/Frizzled9-specific read-outs, we identify G(alpha 16) as a novel downstream effector of Wnt7a/Frizzled9 signaling. Interestingly, G(alpha 16) expression is severely down-regulated, both at the messenger RNA levels and protein levels, in many non small cell lung cancer cell lines. Additionally, through gene-specific knock-downs and expression of GTPase-deficient forms (Q212L) of G(alpha 16), we also establish G(alpha 16) as a novel regulator of non small cell lung cancer cell proliferation and anchorage-independent cell growth. Taken together, our data not only establish the importance of G(alpha 16) as a critical downstream effector of the non-canonical Wnt signaling pathway but also as a potential therapeutic target for the treatment of non small cell lung cancer.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161869)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.